STACEY COX: Open Payments
NPI 1386980837 · HOLLY SPRINGS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$963 in 42 payments from 19 companies in 2025. Trend: 2023 $481 · 2024 $645 · 2025 $963
Food & beverage: $963
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $158 |
| Mannkind Corporation | 6 | $125 |
| CeQur Corporation | 1 | $95 |
| Abbott Laboratories | 4 | $80 |
| Corcept Therapeutics | 3 | $80 |
| Tandem Diabetes Care, Inc. | 4 | $67 |
| Radius Health, Inc. | 2 | $67 |
| Antares Pharma, Inc. | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $31 |
Products named: Ozempic, AFREZZA, CeQur Simplicity, FREESTYLE LIBRE 3, Korlym, t:slim X2 Insulin Pump with Control-IQ, Tymlos, XYOSTED.
Industry payments across GA — which companies pay providers there.
